Craif Inc.

Liquid biopsy startup company. Conducted cancer early diagnosis initiatives / リキッド・バイオプシーのスタートアップ企業。ガンの早期診断の取り組みを実施

Based based in Tokyo, Japan, Craif Inc. works in health.

Profile

"Craif Inc. is an innovative Insurtech startup focused on revolutionizing cancer diagnosis through liquid biopsy technology. With a mission to enable early, painless, and accurate cancer detection using urine tests, Craif Inc. aims to increase survival rates and improve prognoses significantly. Early detection of cancer is crucial for effective treatment, as many cancers are asymptomatic until they reach advanced stages. By providing regular and high-precision cancer diagnosis through non-invasive methods, Craif Inc. is paving the way for early-stage detection and timely intervention. The company's groundbreaking approach to liquid biopsy technology has the potential to transform cancer diagnostics, offering a more accessible and accurate solution for individuals seeking regular cancer screenings and early detection initiatives."

Within the health space, the company focuses on its core offering rather than a broad product line.

The business is associated with Tokyo, Japan.

It is recorded at the Plug and Play accelerated startup stage.

Website: craif.com